The great obesity drug scare of 2023 is now behind ResMed as evidence in the December quarter suggests GLP-1s are actually a ...

The Channel Company at the helm of CRN Australia, continues the expansion of the flagship CRN brand into new regions which included the 2023 launch of CRN Germany and 2024 launch of CRN Asia. CRN’s ...

Our most recent update was on 12 November when we noted that the upside break was a buying opportunity. After rallying towards the high $90’s in December, JBH then underwent another sideways ...

January ended on a slow note as Canadian import tariffs and DeepSeek disruption concerns weighed on buyer sentiment ...

All paying members at FNArena are being reminded they can set an email alert specifically for The Overnight Report. Go to ...

Earnings for Kogan.com missed expectations in the second quarter and most analysts do not share Canaccord Genuity's optimism ...

The head & shoulders reversal pattern remains front and centre. It’s also a pattern that could potentially prove to be a ...

Manual Processes Hamper Progress: A staggering 41% of teams still rely on manual processes for progress claims, leading to bottlenecks and delays. Compliance Risks: 53% of respondents find meeting ...

We’ve all heard the adage “the only two constants in life are death and taxes”, I believe we can add inflation to that list. Whilst everyone is busy dealing with cost-of-living crisis in the present, ...

MELBOURNE, Australia and INDIANAPOLIS, Jan. 31, 2025 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has completed the acquisition from ...

Whitehaven Coal's ((WHC)) December quarter production was in line with or ahead of broker forecasts, while sales were a clear beat of consensus. Managed run-of-mine production of 9.7mt for the quarter ...